page banner
News
Aug 25, 2022
Essential Pharma strengthens its global operating platform in preparation for next stage of growth

Egham, UK - 25 August 2022 - Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces the strengthening of its operating......

Jul 19, 2022
Essential Pharma makes strong progress in its ESG performance and now exceeds sector benchmarks

Egham, UK – 19 July, 2022 – Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces strong year-on-year progress......

Jun 21, 2022
Essential Pharma Appointments Soren Demin as Global Vice-President of Commercial and Head of Business Development

Egham, UK – 21 June, 2022 – Essential Pharma, an international specialty pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces the appointment of Soren Demin......

Apr 6, 2022
Essential Pharma Strengthens its Global Capabilities with New Appointments in Switzerland

Zug, Switzerland - 6 April, 2022 – Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces the global expansion of its......

Mar 30, 2022
Essential Pharma Appoints Andrew Webb as General Counsel

Egham, UK – 30 March 2022 - Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces the appointment of Andrew Webb as......

Dec 16, 2021
Essential Pharma significantly expands its Global Portfolio with product acquisitions for ocular and postpartum therapies from world leading pharmaceutical company

Zug, Switzerland – 16 December, 2021 – Essential Pharma, an international specialty pharma group focused on maintaining access to mature, well-established prescription pharmaceutical products essential to patients across multiple therapeutic areas, announces the......

Nov 25, 2021
Essential Pharma completes two transactions with Rosemont Pharmaceuticals bringing into the portfolio several attractive niche products and streamlining the portfolio to pursue strategic growth ambition
  • Divestments of UK oral liquid products streamlines the portfolio and furthers Essential Pharma’s international growth strategy 
  • Acquired products are low volume, but essential medicines with geographic expansion potential 

Egham, UK......

Jul 21, 2021
Essential Pharma Appoints Georgina Mason as Human Resources Manager

Egham, UK – Essential Pharma, an international specialty pharma company focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces the appointment of Georgina Mason as Human Resources......

May 10, 2021
Essential Pharma Appoints Steen Vangsgaard As Chief Executive Officer

Steen has more than 20 years of experience in the specialty pharma and generics sector gained across a wide range of international commercial operations and companies.

He joins Essential Pharma from Covis Pharma, a global specialty pharmaceutical company that markets therapeutic......

Feb 9, 2021
Essential Pharma Appoints Pharma and Healthcare Operations Expert Colin Brown As Chief Operating Officer

Colin has more than 35 years of experience in the pharmaceutical and consumer healthcare sectors, primarily focused on pharmaceutical development. In addition, he has had roles as diverse as clinical supply manufacturing, quality compliance, project management and business......

Dec 18, 2020
Essential Pharma Welcomes Swift and Successful Conclusion of CMA Priadel Inquiry

Follows Agreement on the Improved Pricing of Priadel with the Department of Health and Social Security 

Egham, UK – 18 December 2020 – Essential Pharma, an international......

Sep 1, 2020
Essential Pharma Appoints Ingvild Liborg As Chief Executive Officer

Essential Pharma, an international pharmaceutical generics company dedicated to supplying well-established, “at risk” products to patients across multiple therapeutic areas, announces the appointment of Ingvild Liborg as Chief Executive Officer. 

Ingvild, who has a......

Apr 1, 2020
Essential Pharma Appoints Ben Ash as Chief Financial Officer

Essential Pharma, an international generic pharmaceutical company dedicated to supplying well-established, “at risk” products to patients across multiple therapeutic areas, announces the appointment of Ben Ash as Chief Financial Officer. 

Ben, who will lead Essential......

Jan 20, 2020
Essential Pharma Embarks on New Era of Growth Following Management Buy Out Supported by Gyrus Capital

Essential Pharma, an international pharmaceutical generics company dedicated to supplying well-established, “at risk” products to patients across multiple therapeutic areas, has been acquired by the company’s management supported by Gyrus Capital, a Swiss private equity......